wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34660607-AF38FD00-A1FC-423D-AEFD-A5BCE2675DBB
Q34660607-AF38FD00-A1FC-423D-AEFD-A5BCE2675DBB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34660607-AF38FD00-A1FC-423D-AEFD-A5BCE2675DBB
Emerging therapeutic targets for synovial sarcoma.
P2860
Q34660607-AF38FD00-A1FC-423D-AEFD-A5BCE2675DBB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34660607-AF38FD00-A1FC-423D-AEFD-A5BCE2675DBB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a0231762c88a8b213316feb0f7dcb01addcba009
P2860
A phase 1 trial and pharmacokinetic study of cediranib, an orally bioavailable pan-vascular endothelial growth factor receptor inhibitor, in children and adolescents with refractory solid tumors.